IL151039A0 - In ovo protection against infectious bronchitis - Google Patents
In ovo protection against infectious bronchitisInfo
- Publication number
- IL151039A0 IL151039A0 IL15103901A IL15103901A IL151039A0 IL 151039 A0 IL151039 A0 IL 151039A0 IL 15103901 A IL15103901 A IL 15103901A IL 15103901 A IL15103901 A IL 15103901A IL 151039 A0 IL151039 A0 IL 151039A0
- Authority
- IL
- Israel
- Prior art keywords
- protection against
- infectious bronchitis
- against infectious
- ovo
- ovo protection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Fodder In General (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Feed For Specific Animals (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51573200A | 2000-02-29 | 2000-02-29 | |
| US09/775,750 US20010046500A1 (en) | 2000-02-29 | 2001-02-02 | In ovo protection against infectious bronchitis |
| PCT/US2001/004792 WO2001064244A2 (en) | 2000-02-29 | 2001-02-15 | In ovo protection against infectious bronchitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL151039A0 true IL151039A0 (en) | 2003-04-10 |
Family
ID=27058588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15103901A IL151039A0 (en) | 2000-02-29 | 2001-02-15 | In ovo protection against infectious bronchitis |
Country Status (20)
| Country | Link |
|---|---|
| EP (2) | EP2198883A1 (pt) |
| JP (1) | JP2003529565A (pt) |
| CN (1) | CN1406135A (pt) |
| AR (1) | AR027558A1 (pt) |
| AT (1) | ATE463253T1 (pt) |
| AU (1) | AU2001237016A1 (pt) |
| BR (1) | BR0108735A (pt) |
| CA (1) | CA2401145A1 (pt) |
| CY (1) | CY1110544T1 (pt) |
| DE (1) | DE60141743D1 (pt) |
| DK (1) | DK1259257T3 (pt) |
| ES (1) | ES2341841T3 (pt) |
| IL (1) | IL151039A0 (pt) |
| MX (1) | MXPA02008254A (pt) |
| NO (1) | NO20024100L (pt) |
| NZ (1) | NZ520761A (pt) |
| PL (1) | PL365447A1 (pt) |
| PT (1) | PT1259257E (pt) |
| WO (1) | WO2001064244A2 (pt) |
| YU (1) | YU65102A (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR031405A1 (es) | 2000-11-21 | 2003-09-24 | Wyeth Corp | Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo |
| WO2004078203A2 (en) * | 2003-03-03 | 2004-09-16 | Akzo Nobel N.V. | Infectious bronchitis virus with an altered spike gene |
| US20100003279A1 (en) * | 2005-12-22 | 2010-01-07 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Vaccine for in ovo inoculation |
| KR20190021334A (ko) | 2016-06-16 | 2019-03-05 | 베링거잉겔하임베트메디카게엠베하 | 감염성 기관지염 바이러스에 대한 백신 |
| BR112021008390A2 (pt) | 2018-10-31 | 2021-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Vacina de ibv h52 com proteína da espícula heteróloga |
| MX2021004907A (es) | 2018-10-31 | 2021-06-15 | Boehringer Ingelheim Vetmedica Gmbh | Vacuna de ibv 4/91 con proteina espicular heterologa. |
| WO2020229249A1 (en) | 2019-05-10 | 2020-11-19 | Boehringer Ingelheim Vetmedica Gmbh | Modified s2 subunit of the coronavirus spike protein |
| WO2020229257A1 (en) | 2019-05-10 | 2020-11-19 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated ibv with extended cell culture and tissue tropism |
| EP3965812A1 (en) | 2019-05-10 | 2022-03-16 | Boehringer Ingelheim Vetmedica GmbH | Modified s1 subunit of the coronavirus spike protein |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0639640T3 (da) * | 1993-07-30 | 2001-01-02 | Akzo Nobel Nv | Fjerkrævaccine indeholdende smitsomt bronchitis-virus serotype 4/91 |
| US6506385B1 (en) * | 1998-04-17 | 2003-01-14 | Embrex, Inc. | Live vaccines and methods of treatment therewith |
-
2001
- 2001-02-15 IL IL15103901A patent/IL151039A0/xx unknown
- 2001-02-15 PL PL01365447A patent/PL365447A1/xx not_active Application Discontinuation
- 2001-02-15 EP EP20100000557 patent/EP2198883A1/en not_active Withdrawn
- 2001-02-15 CN CN01805642A patent/CN1406135A/zh active Pending
- 2001-02-15 EP EP20010909239 patent/EP1259257B1/en not_active Expired - Lifetime
- 2001-02-15 ES ES01909239T patent/ES2341841T3/es not_active Expired - Lifetime
- 2001-02-15 NZ NZ520761A patent/NZ520761A/en unknown
- 2001-02-15 WO PCT/US2001/004792 patent/WO2001064244A2/en active IP Right Grant
- 2001-02-15 YU YUP65102 patent/YU65102A/sh unknown
- 2001-02-15 BR BR0108735A patent/BR0108735A/pt not_active IP Right Cessation
- 2001-02-15 AU AU2001237016A patent/AU2001237016A1/en not_active Abandoned
- 2001-02-15 DK DK01909239T patent/DK1259257T3/da active
- 2001-02-15 PT PT01909239T patent/PT1259257E/pt unknown
- 2001-02-15 JP JP2001563141A patent/JP2003529565A/ja active Pending
- 2001-02-15 AT AT01909239T patent/ATE463253T1/de active
- 2001-02-15 DE DE60141743T patent/DE60141743D1/de not_active Expired - Lifetime
- 2001-02-15 MX MXPA02008254A patent/MXPA02008254A/es unknown
- 2001-02-15 CA CA 2401145 patent/CA2401145A1/en not_active Abandoned
- 2001-02-27 AR ARP010100881 patent/AR027558A1/es not_active Application Discontinuation
-
2002
- 2002-08-28 NO NO20024100A patent/NO20024100L/no not_active Application Discontinuation
-
2010
- 2010-06-03 CY CY20101100486T patent/CY1110544T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ520761A (en) | 2004-10-29 |
| DE60141743D1 (de) | 2010-05-20 |
| JP2003529565A (ja) | 2003-10-07 |
| WO2001064244A2 (en) | 2001-09-07 |
| ATE463253T1 (de) | 2010-04-15 |
| YU65102A (sh) | 2005-09-19 |
| EP1259257B1 (en) | 2010-04-07 |
| PT1259257E (pt) | 2010-06-01 |
| CA2401145A1 (en) | 2001-09-07 |
| NO20024100D0 (no) | 2002-08-28 |
| NO20024100L (no) | 2002-10-09 |
| WO2001064244A3 (en) | 2002-01-31 |
| ES2341841T3 (es) | 2010-06-29 |
| MXPA02008254A (es) | 2003-02-06 |
| PL365447A1 (en) | 2005-01-10 |
| EP1259257A2 (en) | 2002-11-27 |
| AU2001237016A1 (en) | 2001-09-12 |
| EP2198883A1 (en) | 2010-06-23 |
| BR0108735A (pt) | 2002-12-17 |
| AR027558A1 (es) | 2003-04-02 |
| DK1259257T3 (da) | 2010-06-14 |
| CY1110544T1 (el) | 2015-04-29 |
| CN1406135A (zh) | 2003-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2366693B (en) | Software virus protection | |
| AP2002002700A0 (en) | Vaccine composition | |
| HUP0302117A3 (en) | Vaccine composition | |
| GB0020953D0 (en) | Vaccine | |
| IL155282A0 (en) | Vaccines | |
| GB0020089D0 (en) | Vaccine Composition | |
| AU1591402A (en) | Vaccine | |
| GB0024200D0 (en) | Component vaccine | |
| GB0017720D0 (en) | Modified virus | |
| GB0014288D0 (en) | Vaccine | |
| IL151039A0 (en) | In ovo protection against infectious bronchitis | |
| GB0026334D0 (en) | Vaccine | |
| GB0127011D0 (en) | Aircraft protection | |
| GB0003082D0 (en) | Vaccine | |
| GB0027433D0 (en) | Vaccine component | |
| GB0004533D0 (en) | Vaccines | |
| GB0015722D0 (en) | Vaccine | |
| GB0006693D0 (en) | Vaccine | |
| PL365842A1 (en) | Sentinel virus ii | |
| GB0015935D0 (en) | Vaccine | |
| GB0017011D0 (en) | Easy protect | |
| IL135013A0 (en) | Protection against blows | |
| GB0023747D0 (en) | Secure e-mail | |
| GB0103643D0 (en) | Improvements in protecting filis | |
| GB0014280D0 (en) | Vaccines |